An Open Clinical Trial to Evaluate the Safety, Efficacy and Population Pharmacokinetics of Amphotericin B Cholesteryl Sulfate Complex for Injection in Subjects With Invasive Candidiasis and Invasive Aspergillus
Latest Information Update: 15 Apr 2025
At a glance
- Drugs Amphotericin B liposomal (Primary)
- Indications Invasive bronchopulmonary aspergillosis; Invasive candidiasis
- Focus Adverse reactions; Registrational
- Sponsors CSPC Ouyi Pharmaceutical
Most Recent Events
- 09 Apr 2025 Status changed from not yet recruiting to completed.
- 03 Feb 2023 New trial record